Improved Classification of Lung Cancer Using

Radial Basis Function Neural Network with

Affine Transforms of Voss Representation by Adetiba, E. & Olugbara, O. O.
RESEARCH ARTICLE
Improved Classification of Lung Cancer Using
Radial Basis Function Neural Network with
Affine Transforms of Voss Representation
Emmanuel Adetiba, Oludayo O. Olugbara*
ICT and Society Research Group, Durban University of Technology, P.O. Box 1334, Durban, 4000, South
Africa
* oludayoo@dut.ac.za
Abstract
Lung cancer is one of the diseases responsible for a large number of cancer related death
cases worldwide. The recommended standard for screening and early detection of lung
cancer is the low dose computed tomography. However, many patients diagnosed die
within one year, which makes it essential to find alternative approaches for screening and
early detection of lung cancer. We present computational methods that can be implemented
in a functional multi-genomic system for classification, screening and early detection of lung
cancer victims. Samples of top ten biomarker genes previously reported to have the highest
frequency of lung cancer mutations and sequences of normal biomarker genes were
respectively collected from the COSMIC and NCBI databases to validate the computational
methods. Experiments were performed based on the combinations of Z-curve and tetrahe-
dron affine transforms, Histogram of Oriented Gradient (HOG), Multilayer perceptron and
Gaussian Radial Basis Function (RBF) neural networks to obtain an appropriate combina-
tion of computational methods to achieve improved classification of lung cancer biomarker
genes. Results show that a combination of affine transforms of Voss representation, HOG
genomic features and Gaussian RBF neural network perceptibly improves classification
accuracy, specificity and sensitivity of lung cancer biomarker genes as well as achieving
low mean square error.
Introduction
Lung cancer is a malignant tumor in the tissue of human lungs that remains one of the most
leading causes of cancer related death cases worldwide [1]. Low dose Computed Tomography
(CT) is the recommended standard for screening and early detection of lung cancer [2]. How-
ever, the survival rate of lung cancer is very low and more than half of patients diagnosed with
the disease die within one year [3]. Lung cancer develops because of a sustained genetic damage
to normal lung cells by carcinogens from cigarette smoke and other sources. More than 50 ret-
rospective studies of smoking and lung cancer were reported to demonstrate a striking
advancement in the risks of lung cancer for smokers or passive smokers compared to non-
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smokers [4]. In fact, recent studies [5,6] have attested to smoking as indisputably one of the
leading causes of lung cancer, even though approximately 10% of lung cancer cases are attrib-
uted to the carcinogenic effects of radon gas, arsenic, nickel, asbestos, chromium and genetic
susceptibility. The burning of tobacco in cigarette results in chemical processes such as pyroly-
sis, oxidation, hydrogenation, decarboxylation and dehydration of the constituents. Hence,
over 3000 chemicals are produced out of which carcinogens responsible for cancers are phased
into the particulate and vapor phases. The carcinogens in the particulate phase include benzo
(a)pyrene, dibenz(a)anthracene, 5-methylchrysene, benzofluoranthenes, nicotine, N-nitroso-
nornicotene, catechol, nickel, cadmium and polonium. Similarly, the carcinogens in the vapor
phase are hydrazine, vinyl chloride, urethane, formaldehyde, nitrogen oxides and nitroso-
diethylamme. These gamuts of chemicals are either cancer initiators, complete carcinogens,
tumor promoters or co-carcinogens. Consequently, they chemically activate the oncogenes and
deactivate the tumor suppressor genes in the normal lung cell to produce mutations that result
in tumors [7,8].
The availability of huge volumes of lung cancer mutation data has made the treatment of
the disease fast advancing beyond the traditional approaches such as surgery, radiotherapy and
chemotherapy. For a modern treatment of the disease, varieties of drugs to foster ‘personalized
medicine’ have been developed to target the various genetic mutations towards stopping cancer
growth before it becomes advanced and metastatic. These drugs have proven to be highly effec-
tive with fewer side effects in comparison with the traditional chemotherapies. Examples of tar-
geted therapies approved for lung cancer treatment include gefitinib, erlotinib, bevacizumab,
sorafenib and 28-amino-acid peptide (p28). These therapies target mutations in EGFR and
TP53 [9–11]. However, the need to develop genomic based computational methods for classifi-
cation, screening and early detection of lung cancer is highly decisive. This is because the rec-
ommended low dose CT is an imaging based technology that cannot be used for mutation
detection [2,4,7,11]. Automatic genomic based classification, screening and early detection of
lung cancer will go along way to help in recommending victims of known genetic mutations in
the lung to take advantage of the available targeted therapies or participate in clinical trials for
novel drugs.
In [12], DNA methylation markers and neural networks were reported as potentially viable
tools for the automatic classification of lung cancer into Small Cell Lung Cancer (SCLC) and
Non-Small Cell Lung Cancer (NSCLC). Markey et al. [13] developed a Classification And
Regression Tree (CART) trained with 26 features to classify 41 clinical specimens as disease or
non-disease. The features were computed from mass spectroscopy of blood serum samples of
lung cancer and non-cancerous subjects using the mass-to-charge ratio and peak heights of
proteins. Ramani and Jacob [14] designed a computational method using structural and physi-
cochemical properties of protein sequences. They used the Bayesian network in their method
to classify lung cancer tumors into SCLC, NSCLC and COMMON classes. Guan et al. [15] uti-
lized Support Vector Machine (SVM), prior biological knowledge and Prediction Analysis for
Microarray (PAM) to classify adenocarcinoma lung cancer. The aforementioned studies are
necessary steps in the right direction, but unravelling the mutational contents of lung tumors
has not been completely addressed in the literature. This implies that the promises of the tar-
geted therapies to promptly arrest mutations in the lung may be elusive in the absence of rele-
vant methods for screening and early detection of lung cancer mutations. Researchers have
suggested that frequently mutated biomarker genes can be leveraged by designing kits for
screening and early detection of lung cancer [16]. In line with this suggestion, a lung cancer
prediction method was developed in [17]. The method was validated with data sets of EGFR,
KRAS and TP53, which are the top three frequently mutated biomarker genes to predict muta-
tions in lung cancer [16]. Ensemble and non-ensemble variants of Multilayer Perceptron
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(MLP) neural network and SVM were compared to predict six classes of biomarker genes and
the best prediction accuracy of 95.90% was obtained using the MLP neural network ensemble
[17].
The first overarching objective of this study is to extend the genomic coverage of the method
reported in [17] to fourteen classes of the top ten frequently mutated lung cancer biomarker
genes. It was emphasized in the literature that performance of classification algorithms can be
affected for a large number of classes [18]. Consequently, the second objective of this study is
to discover a set of affine invariant genomic features for improved classification of lung cancer
biomarker genes despite the higher number of classes. This particular objective was achieved
by exploring the Z-curve and tetrahedron affine transforms of Voss representation as well as
the Histogram of Oriented Gradient (HOG). The Z-curve and tetrahedron affine transforms
are used as nucleotides transformation methods because they intrinsically generate dimension-
ally reduced representation of Voss transformation with less computational cost [19,20]. More-
over, the affine transformed nucleotides are analogous to color image signals, which makes it
easy to use the HOG method of the image processing domain to extract a set of genomic fea-
tures for improved classification of lung cancer biomarker genes. The third objective of this
study is to obtain an appropriate combination of computational methods for improved classifi-
cation of lung cancer biomarker genes. Combinations of affine transforms of Voss representa-
tion, HOG method, MLP neural network and Gaussian Radial Basis Function (RBF) neural
network we experimentally explored to achieve this objective.
Materials and Methods
Data Set
Normal (non-mutated) nucleotide sequences of ten different biomarker genes were obtained
from the National Center for Biotechnological Information (NCBI) database. The reason for
selecting the NCBI is that it is one of the most widely used databases in the Collaborative Con-
sensus Coding Sequence (CCDS) consortium. The other CCDS databases are Ensembl Genome
Browser, University of California Santa Cruz Genome Browser and Wellcome Trust Sanger
Institute (WTSI) Genome Browser. The CCDS databases provide easy access to the same refer-
ence DNA sequence for any biomarker gene, regardless of the differences in the data and meth-
ods utilized for sequencing. The CCDS consortium tracks high quality identical protein
annotations on the reference mouse and human genomes with a stable identification number
named CCDS ID. The stability of the CCDS ID is because the consortium constantly makes
efforts to ensure that existing CCDS are consistently updated by any collaborating member
[21]. The symbol, description, CCDS ID and number of nucleotides of the top ten lung cancer
biomarker genes used for this study are shown in Table 1.
Mutation data for this study were acquired from the Catalogue of Somatic Mutations in
Cancer (COSMIC) database and they comprise of the top ten biomarker genes in lung cancer.
The COSMIC database developed and hosted by the WTSI contains cases of curated and
archived somatic mutations in the key cancer biomarker genes across many cancer samples
[22]. The top ten biomarker genes in the COSMIC database with the highest frequency of
mutations in the lung as at the time this study was carried out have symbols TP53, EGFR,
KRAS, KMT2C, CDKN2A, NF1, STK11, KMT2D, ZNF521 and SMARCA4 [23]. The symbols
were obtained from the HUGO Gene Nomenclature Committee (HGNC) database and most
of these biomarker genes were specifically reported as frequently mutated biomarker genes in
lung cancer [24–29]. In total, we extracted samples of 10784 lung cancer mutations and the
data set utilized for our experimentation contains fourteen different classes, which are Normal,
EGFR Deletion, EGFR Substitution, KRAS Substitution, TP53 Deletion, TP53 Substitution, NF1
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Substitution, KMT2C Substitution, CDKN2A Substitution, STK11 Deletion, STK11 Substitution,
KMT2D Substitution, ZNF521 Substitution and SMARCA4 Substitution.
The overall statistics of the curated and unique samples of normal and mutations data are
shown in Table 2. The deletion mutation data for biomarker genes like KRAS, NF1, KMT2C,
CDKN2A, KMT2D, ZNF521 and SMARCA in the COSMIC database are either non-existent
or extremely few, which informed our decision to exclude them from our data samples.
Transforming Genomic Nucleotides into Color Images
The gene as a basic unit of heredity is made up of a specific sequence of Deoxyribonucleic Acid
(DNA) or Ribonucleic Acid (RNA). A DNA is a polymer made up of small molecules called
nucleotides that can be distinguished by four bases. These bases are Adenine (A) = C5H5N5,
Table 1. The characteristics of the top ten biomarker genes in lung cancer.
S/N Gene
Symbol
Gene Description CCDS ID Nucleotides
1 TP53 Tumor suppressor p53 CCDS
11118.1
1182
2 EGFR Epidermal Growth Factor Receptor CCDS 5514.1 3633
3 KRAS Kirsten Rat Sarcoma viral oncogene homolog CCDS 8702.1 567
4 KMT2C Lysine (K)-speciﬁc Methyltransferase 2C CCDS 5931.1 14736
5 CDKN2A Cyclin-Dependent Kinase Inhibitor 2A CCDS 6510.1 471
6 NF1 Neuroﬁbromin 1 CCDS
11264.1
8457
7 STK11 Serine/Threonine Kinase 11 CCDS45896.1 1302
8 KMT2D Lysine (K)-speciﬁc Methyltransferase 2D CCDS44873.1 16614
9 ZNF521 Zinc Finger Protein 521 CCDS
32806.1
3936
10 SMARCA4 SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily A,
member 4
CCDS12253.1 4944
doi:10.1371/journal.pone.0143542.t001
Table 2. The statistics of the curated normal andmutation samples.
S/N Description of
Mutation
Count of Curated
Samples
Unique Samples Curated for
Experiment
1 Normal 100 100
2 TP53 Deletion 125 32
3 TP53 Substitution 1483 35
4 EGFR Deletion 1368 35
5 EGFR Substitution 2913 27
6 KRAS Substitution 4058 28
7 KMT2C Substitution 149 35
8 NF1 Substitution 88 35
9 CDKN2A Substitution 98 35
10 STK11 Deletion 32 32
11 STK11 Substitution 124 35
12 KMT2D Substitution 80 35
13 ZNF521 Substitution 105 35
14 SMARCA4 Substitution 61 35
TOTAL 10784 534
doi:10.1371/journal.pone.0143542.t002
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Cytosine (C) = C4H5N3O, Guanine (G) = C5H5N5O and Thymine (T) = C5H6N2O2. Conse-
quently, a DNA can be completely specified by a sequence consisting of the four alphabets {A,
C, G, T}. The first essential step in the processing of a DNA sequence requires its conversion
from a string of alphabets into the numerical equivalent [30–32]. Numerical characterization
of DNA sequences can assist in contriving appropriate genomic features that capture the
essence of the base composition and distribution in a quantitative manner. This could help in
DNA sequence identification and comparison to detect the extent of genetic similarity or dis-
similarity. The base composition provides the total content of each base in a DNA sequence
and is easily determined. However, the base distribution, which is more difficult to determine
is more informative and it gives a better discrimination amongst various genes even if the base
composition numbers are the same [31]. Consequently, both base composition and distribu-
tion of a DNA sequence can be explored to numerically characterize genomic sequences.
The particular numerical encoding method used, determines how well the base composition
and distribution of a DNA sequence is captured. Many numerical encoding methods have been
reported in the literature with each having its strengths and weaknesses [33]. The Voss trans-
formation is one of the most commonly used methods for numeric encoding of nucleotides
[34,35]. It is an efficient spectral detector of the base distribution and periodicity features [33]
and it represents DNA sequences with four binary indicator sequences as:
ub½n ¼
1; ub½n ¼ b
0; ub½n 6¼ b
; 8 b 2 fA; C; G; Tg; n ¼ 0; 1; . . . ;N  1 ð1Þ
(
where 1 denotes the presence of the base b, at location n, 0 signiﬁes its absence at that location
and N is the length of the DNA sequence being encoded. However, the Voss representation is
highly redundant [33]. Some other existing methods such as the Z-curve and tetrahedron afﬁne
transformations can be used to address the redundancy in the Voss representation [36]. The Z-
curve and tetrahedron representations reduce the computational cost in the later processing
stages of DNA sequences.
The Z-curve transformation was developed to encode DNA sequences with more biological
semantics [37]. It uses a suitable geometrical representation to reduce the number of Voss rep-
resentations from four to three in a compact way that is symmetric to all the four bases. The Z-
curve contains all the information carried by the corresponding DNA sequences and therefore,
the analysis of a DNA sequence can be performed by studying the corresponding Z-curve [20].
The 3-dimensional Z-curve vectors are expressed as [20,36]:
xr½n ¼ uA½n  uC½n þ uG½n  uT ½n
xg ½n ¼ uA½n þ uC½n  uG½n  uT ½n; n ¼ 0; 1; . . . ;N  1
xb½n ¼ uA½n  uC½n  uG½n þ uT ½n
ð2Þ
The tetrahedron transformation is similar to the Z-curve transformation, wherein the four
nucleotide bases are transformed into 3-dimensional vectors that point from the center of a tet-
rahedron to its vertices. These 3-dimensional vectors are defined as [36–37]:
xr½n ¼
ﬃﬃﬃ
2
p
3
ð2uT ½n  uC½n  uG½nÞ
xg ½n ¼
ﬃﬃﬃ
6
p
3
ðuC½n  uG½nÞ; n ¼ 0; 1; . . . ;N  1
xb½n ¼
1
3
ð3uA½n  uC½n  uG½n  uT ½nÞ
ð3Þ
Lung Cancer Classification Using RBF-ANNwith Affine Voss
PLOS ONE | DOI:10.1371/journal.pone.0143542 December 1, 2015 5 / 25
where r, g and b in the subscript of the vectors are red, green and blue indicators. In fact, tetra-
hedron transformation has been referred to in the literature as the ‘rgb’ transformation of a
DNA sequence [33].
In order to efficiently process the rgb vectors (Eqs 2 and 3) to obtain the corresponding rgb
images, an appropriate number of windows that corresponds to the image height (H), an
appropriate window size that corresponds to the image width (W) and the overlap are chosen
to define three HxW dimensional matrices. In this study, the number of windows was deter-
mined based on the DNA sequence length (N) in the biomarker gene. The window size of 200
and an overlap of 50 nucleotides were used [38,39]. The matrices were normalized within the
range of 0–255 to portray each of them as a grayscale image. These three grayscale images are
rendered as a color image in the rgb color space.
Pattern Classification and Feature Extraction
The task of pattern classification to be performed by a pattern classifier essentially involves the
cataloguing of raw data into desired classes based on the intrinsic patterns in the data. Auto-
matic pattern classification has been accurately performed in various application areas using
machines [40]. The complexity of a pattern classifier heavily depends on the dimension of the
feature vector and the number of the training data samples. A compact or low dimensional fea-
ture representation that retains the descriptive contents of the original data set is highly desir-
able for efficient memory requirement, speeding up processing time and minimizing
computational complexity of a pattern classifier. Some of the existing feature extraction and
dimensionality reduction methods in statistics are Factor Analysis (FA), Independent Compo-
nent Analysis (ICA) and Principal Component Analysis (PCA).
In signal and image processing domain, several other methods have been developed to
extract representative features of an original data set that result in dimension reduction. These
methods include Vector Quantization (VQ), Scale Invariant Feature Transform (SIFT),
Speeded Up Robust Features (SURF), Principal Component Analysis SIFT (PCA-SIFT), Local
Binary Patterns (LBP) and Histogram of Oriented Gradient (HOG) [41–44]. The HOG is par-
ticularly described in the literature as a strong shape, appearance and texture extraction
method [43–45]. We have selected HOGmethod for use in this study because of its attractive
properties such as better invariance to illumination. Moreover, an earlier study has shown that
the HOG method outperformed the LBP method for the extraction of compact genomic fea-
tures [17]. In the original implementation of the HOGmethod, a 3x3 block of cells and 9 bins
were used to generate a feature vector of 81 elements from a grayscale image and tested to be
ideal for pedestrian detection [44]. However, because of the low dimensions of some genomic
images, we applied minimum dimensions of 2x2 block of cells and 9 bins to generate a compact
HOG genomic feature vector of 36 elements from a grayscale image. The grayscale image was
obtained from a color image of DNA sequence using the MATLAB. The extracted HOG geno-
mic features were subsequently fed into a pattern classifier to classify lung cancer biomarker
genes.
In this study, two rival state-of-the-art pattern classifiers explored for the classification of
lung cancer biomarker genes are the Multilayer Perceptron (MLP) neural network and Radial
Basis Function (RBF) neural network. They are widely used to solve the problems of pattern
classification and function approximation [46–58]. However, the pattern classifiers have intrin-
sic strengths and weaknesses because of their distinguishing properties. MLP neural networks
have the capability to implicitly detect complex non-linear associations between independent
and dependent variables. However, they require greater computational resources and are prone
to the problem of overfitting. On the other hand, RBF neural networks have a strong advantage
Lung Cancer Classification Using RBF-ANNwith Affine Voss
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of being simple to design, they have a good generalization capability, they perform robustly
and are tolerant of input noise [59]. Nevertheless, they may not perform better than MLP neu-
ral networks in all circumstances. The performance of each pattern classifier will obviously
depend on the nature of the problem being considered. MLP neural networks may produce a
more fitted output to cross validation data set than RBF neural networks, but RBF neural net-
works require less trials and error than MLP neural networks. In addition, each pattern classi-
fier may perform differently for diverse approximation functions. Since the underlying
function that approximates our experimental data was unknown beforehand, we found it pru-
dent to experiment with the two pattern classifiers to discover the one that performs well for
the classification task in this study.
Experimental Models and Performance Evaluation
Four experimental models were considered in this study to discover a set of affine invariant
genomic features and to determine an appropriate combination of computational methods for
improved classification of lung cancer biomarker genes. Fig 1 shows the design of a generic
architecture for the four experimental models. The experimental models were implemented
using the MATLAB R2012a programming environment. Based on the experimental models,
experiments were performed on a computer that contains an Intel Core i5-3210M CPU,
which operates at 2.50GHz speed, 6.00GB RAM, 500 GB Hard disk and runs 64-bit Windows 8
operating system. In all the four experimental models, the data set was partitioned into 70%
training, 15% testing and 15% validation. In the first experimental model, the Z-curve repre-
sentation was used to obtain a color image from the Voss representation, HOGmethod was
used to generate a genomic feature vector of 36 elements from the color image and MLP neural
network was used to classify the feature vector. In the second experimental model, the tetrahe-
dron representation was used instead of the Z-curve representation used in the first experimen-
tal model. Consequently, changing the encoding method from the Z-curve to the tetrahedron
Fig 1. The generic architecture of the experimental models.
doi:10.1371/journal.pone.0143542.g001
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is the difference between the first and the second experimental models. In the third experimen-
tal model, the Z-curve representation was used to obtain a color image from the Voss represen-
tation, HOG method was used to generate a genomic feature vector of 36 elements from the
color image and Gaussian RBF neural network was used to classify the feature vector. The
fourth experimental model was designed to use the tetrahedron representation instead of the
Z-curve representation, which is the only difference between this fourth experimental model
and the third experimental model.
The configurations of the MLP neural networks for the first and the second experimental
models are the same. There are 36 neurons in the input layer because the HOG genomic feature
vector has 36 elements. The output layer of the MLP neural network contains 14 neurons
because there are 14 classes in the genomic data set. It has been suggested that more hidden lay-
ers with a high number of neurons usually lead to fewer local minima [60]. Hence, two hidden
layers were considered and the neural network was tested with 100, 200, 300, 400 and 500 neu-
rons to experimentally determine the appropriate number of neurons for each of the hidden
layers. The MLP neural network uses a linear activation function in the input layer to transmit
the exact features without any transformation. The hyperbolic tangent function was used in the
neurons in the hidden and output layers to fully take advantage of their nonlinearity and differ-
entiability properties. These properties are essential qualities for optimal performance of MLP
neural networks [60]. Moreover, the MLP neural network was configured with 500 training
epochs, learning rate of 0.1, maximum training time of 120sec, minimum performance gradi-
ent of 1e-6, validation checks of 500 and performance goal of 0.
The configurations of the Gaussian RBF neural networks in the third and fourth experimen-
tal models are the same. The Gaussian RBF neural networks were configured to have the MSE
goal of 0, spread of 0.1, 36 neurons in the input layer and 14 neurons in the output layer. These
configurations are based on the number of elements in each feature vector and the number of
biomarker gene classes in the data set. However, a Gaussian RBF neural network normally con-
tains one hidden layer and automatically adds neurons to the hidden layer until it meets the
specified mean squared error goal. The training of the Gaussian RBF neural networks was
stopped when the number of hidden layer neurons reached the maximum default value of 534,
which is the number of instances in the training data set.
Four different performance metrics commonly used in the literature to assess the perfor-
mance of a pattern classifier were used to quantitatively evaluate the performances of MLP and
Gaussian RBF neural network pattern classifiers. These performance metrics are the accuracy,
Mean Square Error (MSE), specificity and sensitivity. The accuracy of a pattern classifier can
be computed from the confusion matrix as the percentage of correctly classified entities. This is
equivalent to the sum of diagonal elements of the confusion matrix divided by the total number
of elements in the classes. The MSE is the mean of the square of the difference between the
expected output and the actual output of a pattern classifier. The probability that a pattern clas-
sifier correctly classifies a non-positive instance, as negative is called specificity or True Nega-
tive Rate (TNR). The probability that a pattern classifier labels the instances of the target class
correctly is called sensitivity or True Positive Rate (TPR). The Receiver Operating Characteris-
tics (ROC) is the plot of sensitivity against 1-specificity to graphically illustrate the relationship
between sensitivity and specificity of a pattern classifier [60–62].
Experimental Results
The comparative results of the Z-curve and tetrahedron transforms are first presented to ascer-
tain whether the feature sets obtained with respect to the two affine transforms are invariant.
Figs 2 and 3 respectively show the power spectrum plots of the Z-curve and tetrahedron
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representations of DNA sequences of biomarker genes in Table 1. Each corresponding spec-
trum shape obtained using the Z-curve representation (Fig 2) can be seen to be highly similar
to that obtained using the tetrahedron representation (Fig 3). This result gives an indication of
a strong similarity between the Z-curve and tetrahedron representations. The Z-curve spectral
shapes of the biomarker genes are uniquely different from each other (Fig 2) and the same
trend is observed across the shapes of the biomarker genes obtained using the tetrahedron
Fig 2. The Z-curve power spectral of the biomarker genes in Table 1.
doi:10.1371/journal.pone.0143542.g002
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representation (Fig 3). It can be observed from the two figures, that the spectral shapes of the
TP53 biomarker gene have dense spectral details with spectral envelopes of high amplitudes.
Conversely, the spectral shapes of the EGFR biomarker gene in the two figures contain dense
spectral details of low amplitudes with two spikes of high amplitudes at K = 1200 and
Fig 3. The tetrahedron power spectral of the biomarker genes in Table 1.
doi:10.1371/journal.pone.0143542.g003
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K = 2400. The spectral shapes of the KRAS biomarker gene in both figures have thin spectral
details that terminate before K = 600 without showing any conspicuous spike. The spectral
shapes of the KMT2C biomarker gene have flat spectral details with high amplitude spikes at
K = 5000 and K = 10000 in both figures. Similar to the spectral shapes of the KRAS biomarker
gene, the spectral shapes of the CDKN2A biomarker gene in both figures have thin spectral
details that terminate before K = 500 unlike the spectral shapes of the KRAS biomarker gene
that terminate after K = 500. The spectral shapes of NF1, STK11, KMT2D, ZNF621 and
SMARCA4 biomarker genes all have two spikes of different amplitudes at different values of K,
which is an indication of the uniqueness of these biomarker genes.
In addition, the color images obtained using the Z-curve and tetrahedron representations of
all the biomarker genes in Table 1 are respectively shown in Figs 4 and 5. It is clearly observed
through the subjective visual inspection that the textures of the corresponding images of bio-
marker genes obtained using the two affine transforms are similar. Moreover, it can be seen
Fig 4. The Z-curve transformed color images of all the biomarker genes in Table 1.
doi:10.1371/journal.pone.0143542.g004
Fig 5. The tetrahedron transformed color images of all the biomarker genes in Table 1.
doi:10.1371/journal.pone.0143542.g005
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that the images of TP53, KRAS, CDKN2A and STK11 biomarker genes have heavy textures
and contain conspicuous black or green patches at the bottom right corner of the images. The
textures of the images of EGFR, ZNF521 and SMARCA4 in both figures are coarse with only
the image of SMARCA4 having very tiny black or green patch at the bottom right corner. How-
ever, the images of KMT2C, NF1 and KMT2D biomarker genes have soft textures. Even
though the textures of the corresponding images are similar across each biomarker gene, their
colors are different.
An objective evaluation by quantitatively analyzing the image textures was performed to
complement the results of subjective evaluation of image textures of the biomarker genes (Figs
4 and 5). In doing this, we computed the Haralick second order statistical values of contrast
and homogeneity [63]. High contrast values are usually expected for heavy textures and low
values for soft textures. Homogeneity values are the inverse of contrast values and the higher
the contrast, the lower the homogeneity and vice versal. The Haralick values obtained for each
of the color images of the ten biomarker genes obtained using the Z-curve and tetrahedron rep-
resentations are shown in Table 3. The table shows that the contrast values of the Z-curve
transformed color images rank in a similar manner as those of the tetrahedron transformed
color images (value in bracket denotes the rank of a biomarker gene). For the Z-curve trans-
formed color images, the KRAS biomarker gene ranks first with the highest contrast value of
13099 while KMT2D biomarker gene ranks last with a contrast value of 6358. Meanwhile, for
the tetrahedron transformed color images, the CDKN2A biomarker gene ranks first with the
highest contrast value of 13495 while KMT2D biomarker gene ranks last with a contrast value
of 6392.
The homogeneity values of the Z-curve transformed color images also rank in a similar
manner as those of the tetrahedron transformed color images. For the Z-curve transformed
color images, the KRAS biomarker gene ranks first with a homogeneity value of 0.0342 while
KMT2D biomarker gene ranks last with a homogeneity value of 0.0445. However, for the tetra-
hedron transformed color images, the TP53 biomarker gene ranks first with a homogeneity
value of 0.0339 while the KMT2D biomarker gene ranks last with a homogeneity value of
0.0448. Table 3 shows that only two out of the ten biomarker genes (KRAS and CDKN2A)
have dissimilar rankings between the Z-curve and tetrahedron transformed color images with
respect to the contrast values. In addition, the table shows that with respect to the homogeneity
values, only two out of the ten biomarker genes (KRAS and TP53) have a dissimilar ranking
between the Z-curve and tetrahedron transformed color images. This result implies that 20%
Table 3. Contrast and homogeneity statistical textures for color images of the normal biomarker genes.
Symbol of a Biomarker Gene Z-Curve Transformed Image Tetrahedron Transformed Image
Contrast Homogeneity Contrast Homogeneity
KRAS 13099 (1) 0.0342 (1) 12997 (2) 0.0347 (3)
CDKN2A 12474 (2) 0.0345 (2) 13495 (1) 0.0342 (2)
TP53 12414 (3) 0.0346 (3) 12512 (3) 0.0339 (1)
STK11 12364 (4) 0.0368 (4) 12177 (4) 0.0376 (4)
EGFR 11006 (5) 0.0391(7) 11042 (5) 0.0382 (7)
ZNF521 10975 (6) 0.0383 (5) 11021 (6) 0.0386 (5)
SMARCA4 10450 (7) 0.0390 (6) 10509 (7) 0.0387 (6)
NF1 8801 (8) 0.0421 (8) 8815 (8) 0.0417 (8)
KMT2C 6779 (9) 0.0438 (9) 6761 (9) 0.0436 (9)
KMT2D 6358 (10) 0.0445 (10) 6392 (10) 0.0448 (10)
doi:10.1371/journal.pone.0143542.t003
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of the biomarker genes are disimilarly ranked using the Z-curve and tetrahedron affine trans-
forms. The differences in the ranking values of the contrast and homogeneity are as a result of
the varying colors used by the two affine transforms to render the images of the biomarker
genes.
In addition, a paired t-test was performed to determine if the differences between the sets of
values of the contrast and homogeneity of the Z-curve and tetrahedron transformed color
images are statistically significant. The mean difference between the two sets of the contrast
values (M = 100.1, SD = 2.4e+03, N = 10) is significantly greater than zero, h = 0, tsat = -0.0912
and two-tail p = 0.9283. This statistic indicates a high probability of the result occurring under
the null hypothesis of no difference between the mean of the two sets of contrast values. The
null hypothesis is accepted, because p>0.05 (p = 0.9283) and a 95% CI about mean difference
is (-0.0024, 0.0022). Similarly, the mean difference between the two sets of homogeneity values
(M = 9e-5, SD = 0.0038, N = 10) is greater than zero, h = 0, tstat = 0.0529 and two-tail
p = 0.9584. This statistic indicates a high probability of the result occurring under the null
hypothesis of no difference between the means. The null hypothesis is accepted, because
p>0.05 (p = 0.9584) and a 95% CI about mean difference is (-0.0035, 0.0037). The final result
of the t-test further validates the invariance of the sets of genomic features obtained from the
color images of the Z-curve and tetrahedron transformed DNA sequences.
The next stage concerns the results of the experiments performed based on the four experi-
mental models of this study. In the first experiment, out of the five different experimental trials
with varying number of hidden layer neurons of 100, 200, 300, 400 and 500, the MLP neural
network configuration with 400 neurons in the hidden layer gave the best classification accu-
racy of 75.84%. The confusion matrix from where the accuracy value of this MLP neural net-
work is computed is shown in Table 4. It can be seen in Table 4 that 90 out of the 100 instances
are wrongly classified in the normal class of the dataset, which is not a good result. It can be
observed in the table that 10 instances of the normal class were wrongly classified as TP53 dele-
tion, EGFR substitution, KMT2C substitution, NF1 substitution, CDKN2A substitution,
STK11 substitution, KMT2D substitution, ZNF521 substitution and SMARCA4 substitution
respectively. Moreover, 2 instances of EGFR deletion were wrongly classified as normal, 5
instances of EGFR substitution were wrongly classified as KRAS substitution, 10 instances of
KRAS substitution were wrongly classified as EGFR substitution, 10 instances of STK11
Table 4. The confusionmatrix of the computational method based on the Z-curve, HOG and MLP neural network.
a b c d e f g h i j k l m n Pattern classiﬁed as:
10 0 0 2 0 0 0 0 4 0 0 0 0 0 a = Normal
0 35 0 0 0 0 0 0 0 0 0 0 0 0 b = TP53 Deletion
10 0 27 0 0 0 0 0 0 0 0 0 0 0 c = TP53 Substitution
0 0 0 26 0 0 0 0 0 0 0 0 0 0 d = EGFR Deletion
10 0 0 0 27 10 0 0 0 0 0 0 0 0 e = EGFR Substitution
0 0 0 0 5 25 0 0 0 0 0 0 0 0 f = KRAS Substitution
10 0 0 0 0 0 35 0 0 0 0 0 0 0 g = KMT2C Substitution
10 0 0 0 0 0 0 35 0 0 0 0 0 0 h = NF1 Substitution
10 0 0 0 0 0 0 0 31 0 0 0 0 0 i = CDKN2A Substitution
0 0 0 0 0 0 0 0 0 22 8 0 0 0 j = STK11 Deletion
10 0 0 0 0 0 0 0 0 10 27 0 0 0 k = STK11 Substitution
10 0 0 0 0 0 0 0 0 0 0 35 0 0 l = KMT2D Substitution
10 0 0 0 0 0 0 0 0 0 0 0 35 0 m = ZNF521 Substitution
10 0 0 0 0 0 0 0 0 0 0 0 0 35 n = SMARCA4 Substitution
doi:10.1371/journal.pone.0143542.t004
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deletion were wrongly classified as STK11 substitution and 8 instances of STK11 substitution
were wrongly classified as STK11 deletion.
The ROC curves of the MLP neural network in the first experiment are shown in Fig 6. The
sensitivity of 0.7654 and specificity of 0.9820 results were obtained from the ROC curves using
appropriate functions in MATLAB R2012a. The ROC curve for perfect classification accuracy
is usually the line connecting (0,0) to (0,1) and (0,1) to (1,1) [64]. As shown on the ROC curves
in Fig 6, the performance of the MLP neural network for the normal class is not at all close to
Fig 6. The ROC curves of the computational method based on the Z-curve, HOG andMLP neural network.
doi:10.1371/journal.pone.0143542.g006
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perfect classification while its performance for the other 13 classes are better. None of the other
13 classes can however be said to achieve perfect classification accuracy with this current MLP
neural network configuration as illustrated on the ROC curves, which are only slightly close to
the perfect classification line.
In the second experiment, five trials of the MLP neural network with varying number of
hidden layer neurons of 100, 200, 300, 400 and 500 were also tested. Overall, the MLP neural
network configuration with 200 neurons gave the best classification accuracy of 73.97%. The
confusion matrix for the MLP neural network configuration in the second experiment is
shown in Table 5. The reported accuracy of 73.97% was computed from the confusion matrix
as previously done in the first experiment. Table 5 shows that all the 100 instances of the nor-
mal class were wrongly classified. In particular, it can be seen that in other classes, 1 instance of
the TP53 deletion was wrongly classified as TP53 substitution, 12 instances of EGFR substitu-
tion were wrongly classified as KRAS substitution, 5 instances of KRAS substitution were
wrongly classified as EGFR substitution, 1 instance of STK11 deletion was wrongly classified as
TP53 deletion while 20 instances of STK11 deletion were wrongly classified as STK11 substitu-
tion. There is no considerable improvement in the result of this second experiment when com-
pared to the result of the first experiment.
Fig 7 shows the ROC curves used to compute the sensitivity of 0.7143 and specificity of
0.9812. The ROC curves show that the normal class is poorly classified by the MLP neural net-
work in this second experiment. Although the neural network performed better on the remain-
ing 13 classes similar to what was obtained in the first experiment, the performance of the MLP
neural network for the 13 classes is still not perfect. This is because the ROC curve for each of
the 13 classes is just slightly close to the perfect classification line.
In the third experiment, the classification accuracy obtained from the Gaussian RBF neural
network is 98.88%. The confusion matrix from which the accuracy was computed as was done
in the first and second experiments is shown in Table 6. In this table, it can be seen that all the
100 instances of the normal class were correctly classified. However, 1 instance of NF1 substitu-
tion was wrongly classified as normal and 5 instances of KMT2D substitution were wrongly
classified as normal. This result of the third experiment is a radical improvement when com-
pared to the results of the first and second experiments.
Table 5. The confusionmatrix of the computational method based on the tetrahedron, HOG andMLP neural network.
a b c d e f g h i j k l m n Pattern classiﬁed as:
0 0 0 0 0 0 0 0 0 0 0 0 0 0 a = Normal
0 34 0 0 0 0 0 0 0 1 0 0 0 0 b = TP53 Deletion
10 1 27 0 0 0 0 0 0 0 0 0 0 0 c = TP53 Substitution
10 0 0 28 0 0 0 0 0 0 0 0 0 0 d = EGFR Deletion
0 0 0 0 20 5 0 0 0 0 0 0 0 0 e = EGFR Substitution
10 0 0 0 12 30 0 0 0 0 0 0 0 0 f = KRAS Substitution
10 0 0 0 0 0 35 0 0 0 0 0 0 0 g = KMT2C Substitution
10 0 0 0 0 0 0 35 0 0 0 0 0 0 h = NF1 Substitution
10 0 0 0 0 0 0 0 35 0 0 0 0 0 i = CDKN2A Substitution
0 0 0 0 0 0 0 0 0 11 0 0 0 0 j = STK11 Deletion
10 0 0 0 0 0 0 0 0 20 35 0 0 0 k = STK11 Substitution
10 0 0 0 0 0 0 0 0 0 0 35 0 0 l = KMT2D Substitution
10 0 0 0 0 0 0 0 0 0 0 0 35 0 m = ZNF521 Substitution
10 0 0 0 0 0 0 0 0 0 0 0 0 35 n = SMARCA4 Substitution
doi:10.1371/journal.pone.0143542.t005
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Fig 8 shows the ROC curves used to calculate the sensitivity of 0.9960 and specificity of
0.9991. The curves clearly show that all the 14 classes were properly classified by the Gaussian
RBF neural network in this third experiment. This is because all the curves overlap one another
and are lined very closely or directly on the perfect classification line.
In the fourth experiment, the Gaussian RBF neural network gave classification accuracy of
98.50%. The confusion matrix of the neural network in this fourth experiment from which the
reported accuracy was computed is shown in Table 7. It can be seen from the table that all the
100 instances in the normal class were also correctly classified. However, 1 instance of the
Fig 7. The ROC curves of the computational method based on the Z-curve, HOG andMLP neural network.
doi:10.1371/journal.pone.0143542.g007
Lung Cancer Classification Using RBF-ANNwith Affine Voss
PLOS ONE | DOI:10.1371/journal.pone.0143542 December 1, 2015 16 / 25
KMT2C substitution was wrongly classified as normal, 1 instance of the STK11 substitution
was wrongly classified as normal, 5 instances of KMT2D substitution were wrongly classified
as normal and 1 instance of SMARCA4 substitution was wrongly classified as normal. This
result of the fourth experiment is comparable to the result of the third experiment, but not bet-
ter because 8 instances were wrongly classified when compared to 6 instances that were
wrongly classified in the result of the third experimental model.
Fig 9 shows the ROC curves of all the 14 classes used to calculate the sensitivity of 0.9947
and specificity of 0.9989. The curves show that all the 14 classes were well classified in the
fourth experiment because all the curves closely align or fall directly on the perfect classifica-
tion line. These ROC curves are very close to the curves we obtained in the third experiment,
which further corroborate the closeness of the results obtained from the third and fourth
experiments.
The final result obtained from all the four experimental models in this study is summarized
in Table 8. The MSE values were computed for the MLP and Gaussian RBF neural network
pattern classifiers and reported in Table 8. It can be seen in this table that the results obtained
using a combination of computation methods based on affine transforms of Voss representa-
tion, HOG and Gaussian RBF neural network (that is experimental models 3 and 4) are better
than the results obtained using a combination of affine transforms of Voss representation,
HOG and MLP neural network (that is experimental models 1 and 2). This final result shows
that Gaussian RBF neural network performs better than MLP neural network for the classifica-
tion task considered in this study.
Discussion
The results of the power spectral analysis as shown in Figs 2 and 3 were used in this study to
establish the invariance of the affine transforms of the Voss representation of lung cancer bio-
marker genes. The spectrum of each biomarker gene has a unique shape for the Z-curve affine
transformation (Fig 2). This trend can also be observed in the spectrum of the tetrahedron
affine transformation of each biomarker gene (Fig 3). In agreement with this result, the similar-
ity of the two affine transforms was established by Shao et al. [36]. The authors showed that
there is a strong similarity between the Signal to Noise Ratio (SNR) curves obtained from the
Table 6. The confusionmatrix of the computational method based on the Z-curve, HOG and Gaussian RBF neural network.
a b c d e f g h i j k l m n Pattern classiﬁed as:
100 0 0 0 0 0 0 1 0 0 0 5 0 0 a = Normal
0 35 0 0 0 0 0 0 0 0 0 0 0 0 b = TP53 Deletion
0 0 27 0 0 0 0 0 0 0 0 0 0 0 c = TP53 Substitution
0 0 0 28 0 0 0 0 0 0 0 0 0 0 d = EGFR Deletion
0 0 0 0 32 0 0 0 0 0 0 0 0 0 e = EGFR Substitution
0 0 0 0 0 35 0 0 0 0 0 0 0 0 f = KRAS Substitution
0 0 0 0 0 0 35 0 0 0 0 0 0 0 g = KMT2C Substitution
0 0 0 0 0 0 0 34 0 0 0 0 0 0 h = NF1 Substitution
0 0 0 0 0 0 0 0 35 0 0 0 0 0 i = CDKN2A Substitution
0 0 0 0 0 0 0 0 0 32 0 0 0 0 j = STK11 Deletion
0 0 0 0 0 0 0 0 0 0 35 0 0 0 k = STK11 Substitution
0 0 0 0 0 0 0 0 0 0 0 30 0 0 l = KMT2D Substitution
0 0 0 0 0 0 0 0 0 0 0 0 35 0 m = ZNF521 Substitution
0 0 0 0 0 0 0 0 0 0 0 0 0 35 n = SMARCA4 Substitution
doi:10.1371/journal.pone.0143542.t006
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Z-curve and tetrahedron representations of the Homo sapiens mitochondrion DNA sequences
[36].
Fig 8. The ROC curve of the computational method based on the Z-curve, HOG and Gaussian RBF neural network.
doi:10.1371/journal.pone.0143542.g008
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The sets of HOG genomic features obtained from the color images of the affine transformed
biomarker genes were also established to be invariant in this study. This invariance was estab-
lished by calculating the paired t-test of the Haralick contrast and homogeneity values obtained
from the color images (Table 3). The paired t-test results indicate no statistically significant dif-
ference between the two sets of HOG genomic features obtained from the color images of the
affine transformed biomarker genes. The results of the four experimental models of this study
(Table 8) also established the invariance of the two sets of HOG genomic features used for
improved classification of the lung cancer biomarker genes.
Each experimental model is unique with respect to the combined methods and variation in
the results obtained based on the accuracy, MSE, specificity and sensitivity. The first and sec-
ond experimental models utilized the same configuration of MLP neural network and HOG
genomic features. However, despite the similarity in the pattern classifiers and feature extrac-
tion methods, higher accuracy, specificity, sensitivity and lower MSE were obtained with the
first experimental model compared to the second experimental model. It can be deduced that
an improved classification was recorded using the first experimental model because of the
influence of the Z-curve transformation. Although, using the first experimental model, we
obtained a better classification result when compared to the second experimental model. The
sensitivity of 0.7654 shows that the first experimental model did not result into classifying the
instances of the normal class acceptably. This result is also observed in the confusion matrix of
Table 4 in which 90 out of the 100 instances of the normal class were wrongly classified. How-
ever, the specificity of 0.9820 obtained with the first experimental model is an indication of a
good performance on mutated instances of our data set. This is also observed in Table 4, in
which merely 39 out of the 434 mutated instances were wrongly classified. Meanwhile, because
of the leaning of the result towards the mutated data set only, we cannot recommend a system
based on the first experimental model as being good enough for the improved classification of
the lung cancer biomarker genes.
The third experimental model as shown in Table 8 has led to obtain better classification
result than the first and second experimental models across all the evaluation metrics. The
third experimental model differs from the first experimental model with respect to the pattern
classifier employed. In addition, the third experimental model differs from the second experi-
mental model with respect to the transformation method and pattern classifier employed. The
Table 7. The confusionmatrix of the computational method based on the tetrahedron, HOG and Gaussian RBF neural network.
a b c d e f g h i j k l m n Pattern classiﬁed as:
100 0 0 0 0 0 1 0 0 0 1 5 0 1 a = Normal
0 35 0 0 0 0 0 0 0 0 0 0 0 0 b = TP53 Deletion
0 0 27 0 0 0 0 0 0 0 0 0 0 0 c = TP53 Substitution
0 0 0 28 0 0 0 0 0 0 0 0 0 0 d = EGFR Deletion
0 0 0 0 32 0 0 0 0 0 0 0 0 0 e = EGFR Substitution
0 0 0 0 0 35 0 0 0 0 0 0 0 0 f = KRAS Substitution
0 0 0 0 0 0 34 0 0 0 0 0 0 0 g = KMT2C Substitution
0 0 0 0 0 0 0 35 0 0 0 0 0 0 h = NF1 Substitution
0 0 0 0 0 0 0 0 35 0 0 0 0 0 i = CDKN2A Substitution
0 0 0 0 0 0 0 0 0 32 0 0 0 0 j = STK11 Deletion
0 0 0 0 0 0 0 0 0 0 34 0 0 0 k = STK11 Substitution
0 0 0 0 0 0 0 0 0 0 0 30 0 0 l = KMT2D Substitution
0 0 0 0 0 0 0 0 0 0 0 0 35 0 m = ZNF521 Substitution
0 0 0 0 0 0 0 0 0 0 0 0 0 34 n = SMARCA4 Substitution
doi:10.1371/journal.pone.0143542.t007
Lung Cancer Classification Using RBF-ANNwith Affine Voss
PLOS ONE | DOI:10.1371/journal.pone.0143542 December 1, 2015 19 / 25
accuracy of 98.88%, MSE of 0.011, specificity of 0.9991 and sensitivity of 0.9960 were obtained
with the third experimental model. These performance values indicate that a system based on
Fig 9. The ROC curve of the computational method based on the tetrahedron, HOG and Gaussian RBF neural network.
doi:10.1371/journal.pone.0143542.g009
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the third experimental model is able to classify both the normal and the mutated instances of
the dataset adequately and acceptably. This assertion is also supported by the result in the con-
fusion matrix shown in Table 6, in which all the 100 instances of the normal class were cor-
rectly classified and 428 of the 434 mutated instances were correctly classified. The immediate
inference we can draw from this radical improvement in the result obtained using the third
experimental model when compared to the results obtained using the first and the second
experimental models is the use of Gaussian RBF neural network. This inference is further cor-
roborated by the fact that the result obtained from the fourth experimental model is compara-
ble to the result obtained from the third experimental model. Similar to the third experimental
model, the fourth experimental model has led to improved classification of both normal and
mutated instances of the dataset adequately and acceptably. This is illustrated with the accuracy
of 98.5%, MSE of 0.0016, specificity of 0.9989 and sensitivity of 0.9947. This result is further
espoused by the result shown in the confusion matrix (Table 7), in which all the 100 instances
of the normal class were correctly classified and 426 of the 434 mutated instances were cor-
rectly classified.
The little difference in the results obtained in the third and fourth experimental models may
be attributed to the different colors used in rendering the Z-curve and tetrahedron transformed
images of the biomarker genes. This slight difference can also be seen in Table 3 as conveyed by
the Haralick contrast and homogeneity values. Largely, the results obtained from the third and
the fourth experimental models can be regarded as improvements over the results reported in
[17]. The three most frequently mutated genes in lung cancer used in [17] were also the first
three genes in this current study (Table 1). In that earlier study [17], despite the fewer number
of biomarker genes used, the combination of the Voss representation, the HOG genomic fea-
tures and the MLP ensemble gave the classification accuracy of 95.90% and MSE of 0.0159.
Both third and fourth experimental models of this current study are improvements of the result
in [17] despite the increase in the number of biomarker genes from three to ten coupled with
the use of a single Gaussian RBF pattern classifier rather than a more complicated ensemble
pattern classifier. Moreover, the accuracy of 98.88% obtained in this study is also an improve-
ment over the accuracy of 87.6% obtained in a relatively similar study in [14]. These authors
used Bayesian network and features from protein sequences of lung cancer tumors to classify
the tumors into three classes of Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer
(NSCLC) and COMMON [14]. The study objective of extending the genomic coverage of the
method reported in [17] to the top ten biomarker genes in the COSMIC database [23] has been
successfully achieved.
Based on the results obtained in the current study as displayed in Table 8, we recommend
systems based on the Z-curve and tetrahedron affine transforms, HOG genomic features and
Gaussian RBF neural network for improved classification of lung cancer biomarker genes.
Thus far, we have been able to realize the three important objectives of this study. These
objectives are to extend the genomic coverage of the architecture proposed in [17] from three
to ten biomarker genes. To discover a set of affine invariant genomic features for improved
Table 8. The accuracy, MSE, specificity and sensitivity obtained from the four different experimental models of this study.
Experimental model Afﬁne Transformation Pattern Classiﬁer Accuracy MSE Speciﬁcity Sensitivity
1 Z-curve MLP 0.7584 0.0240 0.9820 0.7654
2 Tetrahedron MLP 0.7397 0.0273 0.9812 0.7143
3 Z-curve RBF 0.9888 0.0011 0.9991 0.9960
4 Tetrahedron RBF 0.9850 0.0016 0.9989 0.9947
doi:10.1371/journal.pone.0143542.t008
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classification of lung cancer biomarker genes despite the higher number of classes. To obtain
the most appropriate combination of computational methods to achieve improved classifica-
tion of lung cancer biomarker genes.
Conclusion
The application of methods from the image processing domain to transform DNA sequences
into the corresponding color images and the classification of lung cancer biomarker genes
based on the genomic features extracted from the color images are the distinctive contributions
of this study. We have successfully extended the genomic coverage of lung cancer classification
to the top ten frequently mutated lung cancer biomarker genes with fourteen different classes.
We have also found a set of affine invariant genomic features using the Z-curve, tetrahedron
and Histogram of Oriented Gradient (HOG). We have performed experiments based on com-
binations of the Z-curve and tetrahedron affine transforms of Voss representation, Histogram
of Oriented Gradient (HOG), Multilayer Perceptron (MLP) neural network and Gaussian
Radial Basis Function (RBF) neural network. This was to experimentally obtain an appropriate
computational methods for improved classification of lung cancer biomarker genes. Results
show that a combination of affine transforms of Voss representation, HOG genomic features
and Gaussian RBF neural network perceptibly improves the classification accuracy, specificity
and sensitivity of lung cancer biomarker genes as well as achieving low mean square errors.
This finding was validated with samples of top ten biomarker genes previously reported to
have the highest frequency of lung cancer mutations and sequences of normal biomarker genes
from the COSMIC and NCBI databases respectively.
The computational methods based on affine transforms of Voss representation, HOG
genomic features and Gaussian RBF neural network as reported in this study can be readily
implemented in a multi-genomic system for classification, screening, early detection and quali-
fication of lung carcinoma victims for targeted molecular therapies. Another prospect of the
computational methods is that their software implementation can be easily interfaced with the
Next Generation Sequencing (NGS) platforms to detect lung cancer mutation profiles of at risk
persons and those with an early onset of lung cancer. This will definitely help with recom-
mending patients for targeted molecular therapies and ultimately reduce lung cancer mortality.
Future work on the proposed computational methods will involve the incorporation of more
biomarker genes and other genetic defects in the lung such as methylation, copy number alter-
ation and loss of heterozygosity. In addition, we hope to explore other feature extraction meth-
ods and perform more intensive comparative studies on other state-of-the art machine
learning methods to further enhance the performance of the computational methods.
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